Replies to post #3188 on Galectin Therapeutics Inc. (GALT)

[jmh0602]

we don't have a partner for psoriasis so I guess not. I think they needed to get above 75% for it to matter. There are patients that don't have improvement with other drugs that GR-MD-02 might help such as the participant in the phase 1 trial, but seems its not enough to gain anyone's interest.